A urine NAD test measures nicotinamide adenine dinucleotide and, more commonly, its breakdown products in your urine. Rather than capturing a single molecule, the test profiles a small family of related metabolites that together reveal how your body is making, using, and disposing of NAD+. The results can reflect anything from your niacin (vitamin B3) intake to how well your kidneys are functioning, and the growing popularity of NAD-boosting supplements has brought the test into wider use outside traditional clinical settings.
What the Test Actually Detects
When people say “urine NAD test,” they usually mean an assay that looks at several molecules rather than NAD+ alone. Under normal circumstances, your body doesn’t dump large amounts of intact NAD+ into urine. Instead, NAD+ is broken down through a series of enzymatic steps, and the end products of that breakdown are what the kidneys filter out. The main metabolites that show up include N1-methylnicotinamide (often abbreviated meNAM or MNA), N1-methyl-2-pyridone-5-carboxamide (called 2-pyridone or 2-pyr), and N1-methyl-4-pyridone-3-carboxamide (4-pyridone or 4-pyr). These are the downstream waste products of nicotinamide, which is itself the immediate breakdown product of NAD+.
A pilot infusion study confirmed this pattern directly: when participants received intravenous NAD+ over six hours, their urine showed significant increases in both intact NAD+ (a 538% jump by the end of the infusion) and methylnicotinamide (up 403%), but nicotinamide itself did not rise significantly in urine.1PubMed Central. A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+ That tells you something useful about how the body handles excess NAD+: it converts it rapidly to methylated metabolites and ships those out rather than letting nicotinamide itself accumulate in the urine. When you see a test result, then, the metabolite profile matters more than any single number.
Why Someone Gets This Test
The oldest and most straightforward reason is to check for niacin deficiency. Pellagra, the disease caused by severe niacin deficiency, can be difficult to diagnose from blood tests alone. One study found that whole blood NAD and NADP concentrations were paradoxically higher in pellagra patients than in healthy controls, an artifact of differences in blood cell concentration between groups.2The Journal of Nutrition. Whole Blood NAD and NADP Concentrations Are Not Depressed in Subjects with Clinical Pellagra Urinary markers sidestep that problem. Clinicians confirm niacin deficiency by checking urinary levels of N1-methylnicotinamide or by running high-pressure liquid chromatography on niacin metabolites in urine.3PubMed Central. Atypical presentation of pellagra with black urine – A clinical conundrum
A second, increasingly common reason is supplement monitoring. People taking nicotinamide mononucleotide (NMN), nicotinamide riboside (NR), or intravenous NAD+ want to know whether the supplement is actually raising their NAD+ levels. Because blood draws are inconvenient and NAD+ in blood can fluctuate rapidly, urine metabolites offer a less invasive window. A review of human NMN trials noted that higher doses of NMN were linked to larger increases in urinary NAD+ metabolites, specifically nicotinamide and 2-pyridone.4PubMed Central. The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials – an Update A urine test after supplementation can give you a rough sense of whether the supplement reached your system and was metabolized.
A third use sits more squarely in the research world. Scientists studying aging, kidney disease, diabetes, and other conditions use urinary NAD metabolite profiles as a readout of how NAD+ metabolism shifts during disease. This isn’t something you’d typically order yourself, but if you’re participating in a clinical trial or seeing a specialist tracking these pathways, it might be part of your workup.
What Low and High Results Suggest
Low urinary excretion of methylated niacin metabolites is a well-established marker of insufficient niacin intake. Research on young men found that daily urinary excretion of less than 1.2 mg of either N1-methylnicotinamide or 2-pyridone reliably identified subjects who were getting very low niacin intakes, around a third of the recommended daily amount.5The Journal of Nutrition. Biochemical Markers for Assessment of Niacin Status in Young Men – Urinary and Blood Levels of Niacin Metabolites In that study, N1-methylnicotinamide turned out to be a slightly better marker than the ratio of 2-pyridone to N1-methylnicotinamide, which is sometimes used as an alternative index. Low results, in other words, strongly suggest your body isn’t getting or processing enough niacin.
High results are harder to interpret because they can mean very different things depending on context. If you’ve recently taken an NAD+ precursor supplement or received an IV NAD+ infusion, elevated urinary metabolites simply confirm the supplement reached your bloodstream and was broken down normally. But persistently high excretion of certain metabolites without supplementation could point to accelerated NAD+ turnover, which happens in some disease states. The key is whether the elevation makes sense given what you’ve been taking and your overall health.
How the Test Is Run
The gold standard for measuring NAD+ and its metabolite family in biological samples is liquid chromatography coupled with mass spectrometry, generally abbreviated LC-MS. Older techniques like colorimetric enzyme assays or basic HPLC with ultraviolet detection are cheaper and available in most labs, but they lack the sensitivity and specificity to reliably quantify these metabolites in human urine.6PubMed Central. NADomics – Measuring NAD+ and Related Metabolites Using Liquid Chromatography Mass Spectrometry LC-MS can distinguish among many structurally similar molecules in a single run, which matters because NAD+ metabolites share chemical features that can cause older methods to confuse one for another.
Direct-to-consumer NAD tests marketed online may or may not use LC-MS. Some rely on simpler assays that measure only one or two metabolites. If you’re considering one of these kits, it’s worth checking what analytical platform the lab uses and exactly which metabolites are reported. A test reporting only total NAD+ in urine gives you less information than one that breaks out the individual metabolites.
Factors That Shift Your Results
Urine NAD metabolite levels are sensitive to a surprisingly wide range of everyday variables. Understanding these is critical before reading too much into any single test result.
Diet is the most obvious factor. NAD+ is made from niacin equivalents in food, primarily niacin itself and the amino acid tryptophan. A meal rich in meat, fish, legumes, or fortified grains will boost NAD+ production and eventually show up as higher metabolite excretion. A restrictive diet low in these foods will do the opposite.
Time of day matters more than most people expect. Nicotinamide catabolites in urine follow a diurnal pattern, meaning the amounts you excrete shift throughout the day independently of what you’ve eaten.7PubMed. Diurnal variations in human urinary excretion of nicotinamide catabolites – effects of stress on the metabolism of nicotinamide A morning sample and an afternoon sample from the same person on the same day can give meaningfully different readings. This is one reason some protocols call for 24-hour urine collection or at least consistent timing between tests.
Exercise creates acute changes in NAD+ metabolism that vary depending on the type and intensity of the workout and even the tissue being studied.8PubMed. Tissue-specific effects of exercise as NAD(+)-boosting strategy – Current knowledge and future perspectives If you ran a hard interval session the morning before your urine test, the results will look different than if you’d had a rest day. For tracking trends over time, keeping your exercise pattern roughly consistent before each sample collection is a reasonable idea.
Individual variation is also substantial. One analytical study of tryptophan-NAD pathway metabolites noted that while lab rats produced relatively uniform urinary profiles, human samples showed much larger variation between individuals.9Journal of Chromatography B. An analytical method for the measurement of acid metabolites of tryptophan-NAD pathway and related acids in urine Genetics, gut microbiome composition, age, and baseline metabolic health all contribute to this spread, which means a single “normal range” is hard to define and your own trajectory over time is usually more informative than any one snapshot.
Sample Handling and Why It Matters
Urine metabolites are not as stable as many people assume. A study examining how storage conditions affect urinary metabolite profiles found that leaving samples at room temperature for a full day significantly altered the concentration of several metabolites, and that more than two freeze-thaw cycles also introduced measurable changes.10PubMed Central. Stability of targeted metabolite profiles of urine samples under different storage conditions That study focused on a broad panel of metabolites rather than NAD-specific ones, but the principle applies: if you’re using a mail-in test kit, how you store and ship the sample can influence the result. Keeping the sample cold and getting it to the lab quickly reduces the odds of degradation artifacts.
The choice between a random (spot) urine sample and a timed collection also affects interpretation. A spot sample is convenient but reflects only what was happening in the hours before you collected it. Correcting for urinary creatinine concentration can partly account for differences in hydration, similar to the way protein-to-creatinine ratios are used in kidney diagnostics to normalize spot samples against 24-hour collections.11PubMed Central. Comparison of random urine protein/creatinine ratio with 24-hour urine protein in suspected pre-eclampsia If your test report shows metabolite levels expressed per milligram of creatinine, that normalization has been applied. If it shows only raw concentrations, hydration status on the day of collection could be skewing the numbers up or down.
NAD Depletion in Disease
Several chronic conditions are associated with depleted NAD+ levels, and researchers are actively studying whether urinary metabolite patterns can serve as early flags or monitoring tools for these diseases.
Kidney disease is a particularly active area. In acute kidney injury, NAD+ levels in kidney tissue drop substantially, impairing the organ’s ability to generate energy and perform its basic transport functions. Conversely, experimental work in animal models suggests that boosting NAD+ can protect the kidney against damage from restricted blood flow, toxic injury, and systemic inflammation.12PubMed Central. NAD+ homeostasis in renal health and disease Because the kidney itself is responsible for filtering NAD+ metabolites into urine, kidney damage can alter the urinary metabolite profile in ways that reflect both local tissue NAD+ depletion and impaired excretion.
Diabetes represents another condition where NAD+ balance goes awry. High blood sugar drives overproduction of NADH (the reduced form of NAD+) through several metabolic routes, while simultaneously the enzyme PARP consumes NAD+ as it tries to repair DNA damage caused by oxidative stress.13Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. Sources and implications of NADH/NAD(+) redox imbalance in diabetes and its complications The result is a shift in the ratio of NADH to NAD+ that affects multiple organs. Whether this shows up clearly in urinary metabolites is still being worked out, but the underlying biochemistry provides a rationale for tracking NAD+ status in diabetic patients.
Aging itself may be the broadest driver of NAD+ decline. The enzyme CD38, which sits on the surface of immune cells and breaks down NAD+ in the extracellular space, becomes more active with age and in a range of diseases including infections, autoimmune disorders, metabolic disease, and cancer.14PubMed Central. The CD38 glycohydrolase and the NAD sink – implications for pathological conditions Rising CD38 activity is thought to be one of the main reasons whole-body NAD+ levels fall as people get older, which in turn has fueled the NAD+ supplement industry and the demand for tests that track whether interventions are working.
Reading Results After Supplementation
If you’re taking NMN, NR, or IV NAD+, a urine test is one of the more practical ways to check whether the supplement is being absorbed and metabolized. The pattern you’d expect to see is a rise in methylated metabolites, particularly methylnicotinamide, 2-pyridone, and 4-pyridone, reflecting the body’s processing and clearance of the extra NAD+ precursors.
The timing of the test relative to supplementation matters a great deal. In mice given NMN, urinary excretion of methylnicotinamide and 4-pyridone spiked dramatically within two days of starting the supplement, then fell back toward baseline by week two.15bioRxiv. Metabolite accumulation from oral NMN supplementation drives aging-specific kidney inflammation That drop doesn’t necessarily mean the supplement stopped working; it could mean the body adapted its clearance rate, or that metabolites were being retained in tissues rather than excreted. The researchers in that study raised the possibility that long-term supplementation in aged animals might lead to metabolite accumulation in kidney tissue, which could trigger inflammation. This is preliminary animal data from a preprint, not a settled conclusion, but it underscores why tracking urine metabolites over multiple time points is more useful than checking once.
A single post-supplement urine sample showing high metabolites tells you the supplement was absorbed. A series of samples over weeks or months tells you how your body’s clearance is changing, which is far more informative. If metabolite levels drop despite continued supplementation, it doesn’t automatically mean your NAD+ levels are falling; it could reflect adaptation in the enzymes that process NAD+ waste products. Conversely, if metabolite levels stay high for weeks, it may mean your body is pushing excess NAD+ precursors out rather than incorporating them into cellular NAD+ pools. Neither pattern has a firmly established clinical meaning yet, but tracking the trend is better than relying on a single data point.
Limitations Worth Knowing
Urine NAD metabolite tests have a few inherent blind spots. First, they reflect what the body is excreting, not what it’s retaining. High urinary NAD+ metabolites could mean your tissues are well-supplied and shedding excess, or they could mean your body is inefficiently converting precursors and wasting them. The test alone can’t distinguish these scenarios without additional context like blood NAD+ levels or clinical symptoms.
Second, standardized reference ranges barely exist for most urinary NAD metabolites. The threshold of less than 1.2 mg per day for methylnicotinamide and 2-pyridone as a marker of deficiency is among the best-validated cutoffs available, and even that comes from controlled feeding studies in young men rather than large population surveys.5The Journal of Nutrition. Biochemical Markers for Assessment of Niacin Status in Young Men – Urinary and Blood Levels of Niacin Metabolites For people outside that demographic, or for metabolites beyond those two, the “normal” range is poorly defined.
Third, many of the companies offering at-home NAD tests are operating in a space with minimal regulatory oversight. The test may be analytically valid in the sense that the lab correctly measures what’s in your sample, but the interpretive report that comes back with it is often based on proprietary reference ranges that haven’t been independently validated. If a report tells you your NAD+ status is “suboptimal,” ask what cutoff they’re using and where it came from.
When Medications and IV Therapies Complicate the Picture
Intravenous NAD+ infusions, which have become popular in wellness clinics, produce dramatic and immediate changes in urinary metabolite profiles. The infusion study referenced earlier showed that a six-hour IV drip boosted urinary NAD+ excretion by over fivefold and methylnicotinamide by roughly fourfold.1PubMed Central. A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+ Those elevations were measured at the end of the infusion; by the next day, levels had already started to come down. If you get a urine NAD test within hours of an IV session, the results will overwhelmingly reflect the infusion rather than your baseline NAD+ status. Waiting at least 24 to 48 hours after an infusion gives a clearer picture of your resting metabolite levels.
Certain medications can also affect niacin metabolism. Isoniazid, a tuberculosis drug, interferes with the conversion of tryptophan to NAD+ and can cause frank niacin deficiency if vitamin supplementation isn’t provided alongside it. Cancer chemotherapies that damage DNA can activate PARP enzymes that consume NAD+, potentially lowering the pool available for normal metabolism. If you’re on any medication known to interact with B-vitamin pathways, mention it when discussing your results with a clinician, because the test can’t tell you why a level is low, only that it is.
Alcohol is another common confounder. Alcohol metabolism consumes NAD+ in the liver, temporarily shifting the NADH-to-NAD+ ratio and potentially changing what gets excreted. Heavy drinking the night before a urine collection could depress NAD+ metabolite levels in the sample even if your long-term NAD+ status is fine. For meaningful results, a few days of typical behavior before collection is a reasonable ground rule.